Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neuroendocrine Tumors|Neuroendocrine Carcinoma|Neuroendocrine Carcinoma Metastatic
Interventions: DRUG: 18F-FDG|DRUG: Injection of hyperpolarized [1-13C]Pyruvate|PROCEDURE: PET/MR/MRS/MRSI scanning
Sponsor: Rigshospitalet, Denmark